IMMUNITYBIO INC (IBRX) Stock Balance Sheet
NASDAQ:IBRX • US45256X1037
Current stock price
7.63 USD
+0.97 (+14.56%)
Last:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 88.33M | 143.43M | 265.45M | 104.60M | 181.10M | |||
| Marketable Securities | 154.48M | 6.38M | 1.01M | 2.50M | 136.00M | |||
| Receivables | 42.62M | 2.65M | 3.17M | 1.90M | 1.30M | |||
| Inventories | 910.00K | 8.27M | N/A | N/A | N/A | |||
| Other Current Assets | 28.53M | 23.85M | 24.45M | 31.50M | 15.90M | |||
| Total Current Assets | 314.88M | 184.59M | 294.08M | 140.60M | 334.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 147.27M | 170.46M | 182.68M | 189.60M | 119.20M | |||
| Investments And Advances | N/A | 0.00 | 891.00K | 800.00K | 800.00K | |||
| Goodwill | 910.00K | 910.00K | N/A | N/A | N/A | |||
| Intangibles | 13.04M | 15.02M | 17.09M | 20.00M | 1.40M | |||
| Other Non-Current Assets | 18.42M | 4.83M | 2.82M | 4.70M | 6.80M | |||
| Total Non-Current Assets | 187.02M | 198.35M | 210.37M | 221.80M | 134.60M | |||
| TOTAL ASSETS | 501.90M | 382.93M | 504.45M | 362.40M | 468.90M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 431.90M | 299.20M | |||
| Current Portion Of LT Debt. | 1.75M | 1.25M | 1.48M | 1.40M | 3.94M | |||
| Accrued Expenses | 52.62M | 46.80M | 46.48M | 43.10M | 54.40M | |||
| Accounts Payable | 6.98M | 6.72M | 9.20M | 21.00M | 11.40M | |||
| Other Current Liabilities | 403.00K | 173.00K | 1.14M | 3.50M | 3.90M | |||
| Total Current Liabilities | 61.75M | 54.94M | 58.28M | 500.90M | 369.00M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 801.71M | 746.28M | 836.95M | 241.30M | 306.30M | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | 200.00K | |||
| Other Non-Current Liabilities | 138.01M | 69.84M | 195.15M | 70.00M | 37.30M | |||
| Total Non-Current Liabilities | 940.61M | 817.09M | 1.03B | 308.80M | 342.10M | |||
| TOTAL LIABILITIES | 1.00B | 872.03M | 1.09B | 809.70M | 711.10M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -3.73B | -3.38B | -2.96B | -2.38B | -1.96B | |||
| Additional Paid In Capital | 3.20B | 2.88B | 2.37B | 1.93B | 1.72B | |||
| Minority Interest | 895.00K | 969.00K | 1.05M | -2.50M | -1.70M | |||
| Common Shares | 101.00K | 85.00K | 67.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 28.96M | 1.20M | 10.00K | 200.00K | 0.00 | |||
| Shares Outstanding | 1.01B | 852.90M | 670.87M | 421.40M | 397.70M | |||
| Tangible Book Value per Share | -0.51 | -0.59 | -0.90 | -1.11 | -0.61 | |||
| Total Shareholders' Equity | -500.47M | -489.10M | -586.99M | -447.30M | -242.20M | |||
| TOTAL LIABILITIES AND EQUITY | 501.90M | 382.93M | 504.45M | 362.40M | 468.90M | |||
| Statistics | ||||||||
| Debt/Equity | -1.60 | -1.53 | -1.43 | -1.51 | -2.50 | |||
| Current Ratio | 5.10 | 3.36 | 5.05 | 0.28 | 0.91 | |||
| Return On Assets (ROA) | -70.01% | -108.00% | -115.61% | -114.95% | -73.96% | |||
| Return On Equity (ROE) | N/A | N/A | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21